AAV-VEGF-eGFP induced rapid and sustained motor recovery as measured by the single-seed reaching task, whereas AAV-eGFP injected mice showed little improvement up to four weeks post-stroke (Fig. 7d). The gene discussed is VEGFA; the disease is stroke disorder.